$426 Million is the total value of Ghost Tree Capital, LLC's 49 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 101.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SERIES TRUSTput | $72,140,000 | +138.1% | 850,000 | +142.9% | 16.92% | +162.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $24,854,000 | -8.7% | 1,538,000 | -21.0% | 5.83% | +0.8% |
| IMMU | New | IMMUNOMEDICS INCcall | $21,008,000 | – | 1,300,000 | +100.0% | 4.93% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $15,785,000 | +176.4% | 250,000 | -1.0% | 3.70% | +205.2% |
| CELG | New | CELGENE CORPcall | $15,654,000 | – | 150,000 | +100.0% | 3.67% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $15,143,000 | – | 230,000 | +100.0% | 3.55% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $13,753,000 | -2.0% | 115,000 | +15.0% | 3.22% | +8.3% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $12,789,000 | +64.7% | 325,000 | +30.0% | 3.00% | +81.9% |
| AGN | New | ALLERGAN PLCcall | $12,269,000 | – | 75,000 | +100.0% | 2.88% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $11,312,000 | – | 150,000 | +100.0% | 2.65% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $10,950,000 | – | 600,000 | +100.0% | 2.57% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $10,953,000 | – | 225,000 | +100.0% | 2.57% | – |
| MYL | New | MYLAN N V | $10,578,000 | – | 250,000 | +100.0% | 2.48% | – |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $10,015,000 | +38.1% | 250,000 | +25.0% | 2.35% | +52.5% |
| AVXS | Sell | AVEXIS INC | $9,407,000 | -7.0% | 85,000 | -18.7% | 2.21% | +2.7% |
| BMY | BRISTOL MYERS SQUIBB COcall | $9,192,000 | -3.9% | 150,000 | 0.0% | 2.16% | +6.2% | |
| XLRN | Sell | ACCELERON PHARMA INC | $8,488,000 | -35.0% | 200,000 | -42.9% | 1.99% | -28.3% |
| VRAY | Buy | VIEWRAY INC | $8,334,000 | +106.7% | 900,000 | +28.6% | 1.95% | +128.3% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $7,995,000 | -55.2% | 325,000 | -22.8% | 1.88% | -50.6% |
| AGN | New | ALLERGAN PLC | $7,484,000 | – | 45,750 | +100.0% | 1.76% | – |
| ZGNX | Sell | ZOGENIX INC | $7,209,000 | -65.7% | 180,000 | -70.0% | 1.69% | -62.1% |
| SAGE | Sell | SAGE THERAPEUTICS INCput | $7,198,000 | -23.0% | 43,700 | -70.9% | 1.69% | -14.9% |
| JUNO | Buy | JUNO THERAPEUTICS INC | $6,857,000 | +52.9% | 150,000 | +50.0% | 1.61% | +68.7% |
| CLVS | New | CLOVIS ONCOLOGY INC | $6,800,000 | – | 100,000 | +100.0% | 1.60% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $6,436,000 | – | 200,000 | +100.0% | 1.51% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $6,400,000 | – | 500,000 | +100.0% | 1.50% | – |
| OBSV | New | OBSEVA SA | $6,023,000 | – | 617,100 | +100.0% | 1.41% | – |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $5,983,000 | +20.7% | 158,200 | -20.9% | 1.40% | +33.2% |
| HZNP | New | HORIZON PHARMA PLC | $5,840,000 | – | 400,000 | +100.0% | 1.37% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $4,991,000 | – | 185,000 | +100.0% | 1.17% | – |
| INCY | Buy | INCYTE CORP | $4,736,000 | +15.9% | 50,000 | +42.9% | 1.11% | +28.0% |
| AQXP | AQUINOX PHARMACEUTICALS INC | $4,704,000 | -17.1% | 400,000 | 0.0% | 1.10% | -8.5% | |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $4,515,000 | – | 500,000 | +100.0% | 1.06% | – |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $3,643,000 | -48.0% | 65,000 | -51.9% | 0.85% | -42.6% |
| SAGE | New | SAGE THERAPEUTICS INC | $3,547,000 | – | 21,537 | +100.0% | 0.83% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $3,522,000 | – | 150,000 | +100.0% | 0.83% | – |
| ITEK | New | INOTEK PHARMACEUTICALS CORP | $3,393,000 | – | 1,300,000 | +100.0% | 0.80% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $3,364,000 | – | 175,000 | +100.0% | 0.79% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $3,201,000 | +14.6% | 825,000 | -25.0% | 0.75% | +26.6% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $3,060,000 | -16.4% | 300,000 | -25.0% | 0.72% | -7.6% |
| DERM | New | DERMIRA INC | $2,781,000 | – | 100,000 | +100.0% | 0.65% | – |
| KDMN | Sell | KADMON HLDGS INC | $2,534,000 | -11.0% | 700,000 | -17.6% | 0.59% | -1.8% |
| ABLX | New | ABLYNX NVsponsored adr | $2,249,000 | – | 90,000 | +100.0% | 0.53% | – |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $2,151,000 | – | 550,000 | +100.0% | 0.50% | – |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $2,085,000 | -77.2% | 500,000 | -47.4% | 0.49% | -74.8% |
| EDIT | New | EDITAS MEDICINE INC | $1,997,000 | – | 65,000 | +100.0% | 0.47% | – |
| Buy | NABRIVA THERAPEUTICS PLC | $1,196,000 | +21.7% | 200,000 | +66.7% | 0.28% | +34.0% | |
| FXB | Sell | CURRENCYSHS BRIT POUND STERbrit pound ste | $1,194,000 | -69.6% | 9,100 | -69.8% | 0.28% | -66.4% |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $727,000 | – | 25,000 | +100.0% | 0.17% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -275,000 | -100.0% | -0.14% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -100,000 | -100.0% | -0.15% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -187,450 | -100.0% | -0.20% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -64,410 | -100.0% | -0.26% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -53,500 | -100.0% | -0.28% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -30,000 | -100.0% | -0.35% | – |
| IRIX | Exit | IRIDEX CORP | $0 | – | -199,519 | -100.0% | -0.40% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.42% | – |
| PTCT | Exit | PTC THERAPEUTICS INCcall | $0 | – | -100,000 | -100.0% | -0.42% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -35,000 | -100.0% | -0.43% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -500,000 | -100.0% | -0.56% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.64% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -235,000 | -100.0% | -0.73% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.77% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -0.79% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -109,000 | -100.0% | -0.87% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.87% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -65,000 | -100.0% | -0.88% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.96% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -75,000 | -100.0% | -1.02% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -50,000 | -100.0% | -1.08% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -345,284 | -100.0% | -1.18% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -100,000 | -100.0% | -1.23% | – |
| PDCO | Exit | PATTERSON COMPANIES INC | $0 | – | -160,000 | -100.0% | -1.31% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -550,000 | -100.0% | -1.44% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -1.52% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.61% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -65,000 | -100.0% | -1.65% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -275,000 | -100.0% | -1.70% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -75,000 | -100.0% | -1.86% | – |
| INSM | Exit | INSMED INCcall | $0 | – | -300,000 | -100.0% | -1.99% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -50,000 | -100.0% | -2.01% | – |
| INSM | Exit | INSMED INC | $0 | – | -324,400 | -100.0% | -2.15% | – |
| ENTL | Exit | ENTELLUS MED INC | $0 | – | -561,510 | -100.0% | -2.20% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -115,000 | -100.0% | -2.22% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -225,000 | -100.0% | -2.93% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Aput | $0 | – | -403,500 | -100.0% | -3.64% | – |
| AVXS | Exit | AVEXIS INCput | $0 | – | -200,000 | -100.0% | -4.11% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -650,000 | -100.0% | -4.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.